In the present work the interaction between bovine herpesvirus 4 (BoHV-4)-infected bovine endometrial stromal cells (BESCs) and interferon gamma (IFNG) was investigated. Starting from the particular tropism of BoHV-4 toward BESCs, a pure population of these cells, free of CD45-positive cells, was prepared and proven to have a bona fide mesenchymal derivation as shown by vimentin-positive and cytokeratinnegative staining. BESCs expressed functional IFNG receptors (IFNGR) 1 and 2 but not IFNG ligand. BESCs transfected with a new reporter construct made by cloning the bovine indoleamine 2, 3-dioxygenase 1 (IDO1) promoter in front of the luciferase reporter gene responded to exogenous IFNG treatment. Further, IFNG-treated or constitutively secreting IFNG BESCs strongly restricted BoHV-4 replication and consequent cytopathic effect. IDO1 expression in BESCs was tightly induced by IFNG and IDO1 was previously shown to be the mediator for some of the IFNG pathogenostatic effects. However, IDO1 inhibitors and IDO1 constitutive expression could not respectively abrogate or recapitulate IFNG effect on BoHV-4-infected BESCs, whereas BoHV-4 immediate early (IE2) gene expression was transcriptionally depressed by IFNG axis activation independently from IDO1 expression; this was further confirmed by revealing a BoHV-4 IE2 gene promoter area containing potential responsive elements interacting with inhibitory transcription factors induced by IFNG in BESCs. The data achieved in this work highlight at least two issues: first, the role of BESCs as target/ effector cells for the IFNG; second, the importance of uterine IFNG integrity to control BoHV-4 infection recrudescence from a persistent/latent state to a chronic disease, endometritis.
INTRODUCTION
A dairy herd's reduced reproductive efficiency greatly increases the cost of its health management through the loss of pregnancies as well as through decreased milk production. Bovine uterine diseases are one of the main causes of infertility in dairy herds and, as a consequence, they have a major impact on the economic performance of dairy herds. Therefore, it is very important to understand the etiology and pathogenesis of these diseases for their correct prevention and/or treatment. Bovine uterine infections are mainly associated with bacteria contaminating the environment, which infect the vagina mainly during parturition; the primary site of infection is represented by the epithelial layer of the uterus [1] . On the other hand, the role of uterine infection of viral origin coming through the systemic route in chronically infected animals, involving the stromal layer of the uterus as a primary site of infection, is often neglected. Among these, bovine herpesvirus 4 (BoHV-4) has been most consistently associated with uterine diseases in postpartum cattle, mostly as a secondary agent and along with different bacteria species. Escherichia coli and Arcanobacterium pyogenes are the most prevalent, followed by a range of anaerobic bacteria including Prevotella spp., Fusobacterium necrophorum, and Fusobacterium nucleatum [2, 3] . A complex coinfection model for BoHV-4 as a cofactor for the development of bovine postpartum metritis was hypothesized where BoHV-4-persistently infected animals harbor BoHV-4 persistent infection within the macrophages [4, 5] . During parturition, infection of the uterus can take place from environmental bacteria. However, such infection, in normoergic animals, is cleared within 3 wk [1, 6] , whereas in BoHV-4-persistently infected animals, the inflamed uterus attracts BoHV-4-persistently infected macrophages from the periphery to the site of inflammation. Inflammatory molecules produced by the inflamed endometrium and proliferating bacteria, such as prostaglandin E2 (PGE2) and lipopolysaccharide (LPS), induce the replication of BoHV-4 in persistently infected macrophages [7] , and consequently endometrial stromal cells can become infected with newly replicating virus. Furthermore, tumor necrosis factor alpha (TNFA) produced by LPS-induced macrophages [8] binds TNFA receptor 1 on the surface of BoHV-4-infected endometrial stromal cells, thus inducing BoHV-4 IE2 gene expression and enhanced BoHV-4 replication. The IE2 gene product ORF50/Rta (replication and transcription activator) induces not only BoHV-4 replication [9] but also interleukin 8 (IL-8) production [10] , thus shifting the inflammation from a transitory and acute status (metritis) toward a chronic status (endometritis) [7, [10] [11] [12] [13] .
The first isolation of BoHV-4 from a case of bovine metritis was reported in the United States in 1973 [14] . Postpartum metritis has also been associated with BoHV-4 in the United States [15] , Spain [16] , and Serbia [17] . Several other isolates have been associated with reproductive disorders [18] , and BoHV-4 seroprevalence has been associated with postpartum metritis and chronic infertility in cattle [19] . Although these epidemiological observations, corroborated by experimental evidence at the molecular level, are progressively validating the role of BoHV-4 on bovine endometritis, many questions need to be answered. With regard to this, in our opinion a special interest must be focused on the reasons why only some animals harboring BoHV-4 develop postpartum metritis, as well as on the host factors limiting the clinical outcome of the infection in those animals harboring the virus but not developing the disease.
Taking into account that interferon gamma (IFNG) has been shown to be up-regulated in cases of BoHV-4 infection [20] , molecules belonging to this category probably play a pivotal role in the antiviral response of the infected animals. Furthermore, a link between IFNG production in pregnant dairy cows naturally infected with the intracellular parasite Neospora caninum and protection against abortion has also been observed [21] .
IFNG, which is considered to be mainly produced by T lymphocytes and natural killer (NK) cells, can strengthen innate immunity via induction of antimicrobial factors, or degradative pathways, in other immune cells, such as macrophages. BoHV-4 that can establish persistent infections in cattle, particularly in macrophages [5] , has a remarkable tropism for those same uterine histological locations (endometrial stromal cells [22] and endometrial stromal layer), where also T lymphocytes and NK cells can be mainly found [23] . In the present paper a relationship between IFNG axis activation and BoHV-4 replication restriction in bovine endometrial stromal cells (BESCs) is unveiled, paving the way to new potential treatment and prevention of uterine disease.
MATERIALS AND METHODS

Endometrial Stromal Cell Isolation and Primary Culture
For a more comprehensive understanding of the interaction of potential pathogens or specific ligands, like cytokines or growth factors, with the endometrial substrate it is essential to use a population of pure cells, without leukocyte contamination, obtained from pathogen-free animals. Moreover, these cells must be in the same endocrine status and must be able to maintain their biological characteristics, in terms of response, during the different passages of the culture experiments. Endometrial stromal cell isolation was performed as previously described [24] , with minor modifications [11] . The intercaruncular areas of the endometrium from three postpubertal nonpregnant BoHV-4 serum-negative animals with no evidence of genital disease were cut into strips and placed into serum-free Roswell Park Memorial Institute medium (RPMI-1640; Sigma) supplemented with 50 IU/ml penicillin, 50 lg/ml streptomycin, and 2.5 lg/ml amphotericin B (Sigma), working under sterile conditions. The strips were then chopped into 1-mm 3 pieces and placed into Hanks balanced salt solution (HBSS; Sigma), and tissue was digested in 25 ml sterile filtered digestive solution, which was made by dissolving 50 mg trypsin III (Roche), 50 mg collagenase II (Sigma), 100 mg bovine serum albumin (BSA; Sigma), and 10 mg DNase I (Sigma) in 100 ml phenol red-free HBSS. Following a 1.5-h incubation in a shaking water bath at 378C, the cell suspension was filtered through a 40-lm mesh (Fisher Scientific) and the filtrate was resuspended in phenol red-free HBSS containing 10% fetal bovine serum (FBS; Sigma) and 3 lg/ml trypsin inhibitor (washing medium; Sigma). The suspension was centrifuged at 100 g for 10 min, and following two further washes in washing medium the cells were resuspended in RPMI-1640 containing 10% FBS, 50 IU/ml penicillin, 50 lg/ml streptomycin, and 2.5 lg/ml amphotericin B. The cells were plated at a density of 1 3 10 5 cells in 2 ml per well using 24-well plates (Nunc). To obtain separate stromal cells from the epithelial cell populations, the cell suspension was removed 8 h after plating, which allowed selective attachment of stromal cells. The absence of immune cells in the uterine cell cultures was confirmed by RT-PCR for the CD45 pan-leukocyte marker as previously described [25] . The culture medium was changed every 48 h until the cells reached confluence. All cultures were maintained at 378C with 5% CO 2 in air in a humidified incubator.
Reagents
Recombinant full-length mature bovine IFNG protein was purchased from Abcam (ab87928) and L-tryptophan and 1-methyl-L-tryptophan (1-MT) from Sigma (T0254-25G and 447439-5G, respectively).
Cell Lines
Human embryo kidney cells 293T (HEK 293T, ATCC: CRL-11268), Madin Darby bovine kidney (MDBK; ATCC: CCL-22), bovine embryo kidney (BEK; BS CL-94; from Dr. M. Ferrari, Istituto Zooprofilattico Sperimentale, Brescia, Italy) and BEK-expressing cre recombinase (BEKcre) [26] cell lines were cultured with complete growth medium Dulbecco modified essential medium (DMEM; Sigma) containing 10% FBS, 2 mM L-glutamine, 100 IU/ml penicillin (Sigma), 100 lg/ml streptomycin (Sigma), and 2.5 lg/ml of amphotericin B and incubated at 378C, 5% CO 2 in a humidified incubator.
Transient Transfection and Luciferase Reporter Assay
Confluent BESCs in 24-well plates were cotransfected with reporter or/and effector plasmids using LTX transfection reagent (Invitrogen) prepared in DMEM without serum and antibiotics and left on the cells for 6 h at 378C with 5% CO 2 in air in a humidified incubator. The transfection mixture was replaced with complete medium (RPMI-1640, 10% FBS, 50 IU/ml of penicillin, 50 lg/ ml of streptomycin, and 2.5 lg/ml of amphotericin B) and treated or not treated with IFNG.
Luciferase reporter assays were performed using a Dual Luciferase Reporter Assay System Kit (Promega) with minor modifications. Following transfection and treatment, cells were washed with PBS and lysed with 100 ll of lysis passive buffer by freeze-thawing at 808C. Then 20 ll of the cell lysate was added to 50 ll of luciferase assay reagent and luciferase activity was determined with a Victor 3 Multilabel Counter (PerkinElmer) according to the manufacturer's instructions.
Viruses and Viral Replication
BoHV-4-EFGPDTK [27] and BoHV-4-A-LucDTK [28] were propagated by infecting confluent monolayers of BEK or MDBK cells at a multiplicity of infection (M.O.I.) of 0.5 50% tissue culture infectious doses (TCID50) per cell and maintained in minimal essential medium (MEM; Sigma) with 2% FBS for 2 h. The medium was then removed and replaced with fresh MEM containing 10% FBS. When approximately 90% of the cell monolayer exhibited cytopathic effect (CPE; 72 h postinfection [P.I.]), the virus was prepared by freezing and thawing cells three times and pelleting the virions through 30% sucrose, as described previously [29] . Virus pellets were resuspended in cold MEM without FBS. TCID50 was determined with MDBK cells by limiting dilution. For viral replication, the supernatants of infected cultures were harvested after 48 and 72 h, and the amount of infectious virus was determined by limiting dilution on BEK cells.
Generation of Stably Transfected BESCs
BESCs from a subconfluent 75-cm 2 flask were electroporated (Equibio apparatus; 300 V, 25 lF, 240 V, 1050 lF, and 481 R; Opty-Pulse) with 10 lg of pbIFNG or pbIDO1P-Luc DNA in DMEM high with 10% FBS. Electroporated cells were returned to new 75-cm 2 flasks and fed with complete medium (MEM containing 10% FBS, 50 IU/ml of penicillin, 50 lg/ml streptomycin, 2.5 lg/ml amphotericin B, and 2 mM L-glutamine). Twenty-four hours after electroporation, cells were selected with 500 lg/ml of G418 (Sigma) until visible colonies appeared on the surface of the flask. Ten G418-resistant cell colonies were encircled with a small cloning cylinder (Corning), and the cells within the cylinder were harvested, plated in a 24-well plate, and grown until they reached confluence. The clones were selected based on their ability to secrete IFNG as measured by ELISA (Duo Set Bovine Interferon Gamma; R&D Systems). Although all clones secreted IFNG, only three of them were kept for further expansion and analysis.
Western Immunoblotting
Protein cell extracts were obtained from 25-cm 2 confluent flasks of BESCs by adding 100 ll of cell extraction buffer (50 mM Tris-HCl, 150 mM NaCl, and 1% NP-40; pH 8). Cell extracts containing 50 lg of total protein were electrophoresed through 10% SDS-PAGE and transferred to nylon membranes by electroblotting. Membranes were incubated with mouse anti-indoleamine 2,3-dioxygenase (IDO) monoclonal antibody (clone 10.1, cat. 05-840; Millipore), probed with horseradish peroxidase-labeled anti-mouse immunoglobulin antibody (Sigma), and visualized by enhanced chemiluminescence (ECL Kit; Pierce). JACCA ET AL.
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Cell Immunostaining
At the second or third passage, 2.5 3 10 5 BESCs were seeded in a six-well plate and incubated at 378C with 5% CO 2 in air in a humidified incubator. When BESCs were subconfluent the culture medium was removed and the cells were fixed with acetone/methanol solution (1:1 proportion) for 20 min at room temperature (RT). After two quick washes with PBS, the fixed cells were blocked for 1 h at RT with 10% FBS diluted in PBS þ 1% BSA. Subsequently, cells were washed with PBS and incubated with the primary antibody diluted in PBS þ 1% BSA for 1 h at RT; the antibody was then removed and the cells washed extensively with PBS three times for 3 min each. Cells were incubated with the secondary antibody and diluted 1:500 in PBS þ 1% BSA for 1 h at RT in the dark and then washed for three times with PBS. As a counterstain, 4 0 ,6-diamidino-2-phenylindole, dilactate (DAPI) was added to the cells and incubated for 10 min in the dark; after a final PBS washing cells were observed under the microscope. As primary antibodies, we used anti-alphavimentin mouse monoclonal antibody (diluted 1:200; sc-32322; Santa Cruz Biotechnology Inc.), anti-cytokeratin (CK) 14 rabbit polyclonal antibody (diluted 1:500; PRB-155P; Covance), and anti-CK18 mouse monoclonal antibovine antibody (diluted 1:200; KS-B17.2; Sigma), and as a secondary antibody we used goat anti-mouse IgG AlexaFluor 488 conjugated (A11029, Life Technologies), goat anti-mouse AlexaFluor 594 conjugated (A11032, Life Technologies) and goat anti-rabbit AlexaFluor 594 conjugated (A11037, Life Technologies). These antibodies had been previously validated for bovine specimens [30] .
In Vivo Bioluminescence Imaging
We seeded 5 3 10 4 BESCs in 24-well plates and incubated them at 378C with 5% CO 2 in air in a humidified incubator. When BESCs were subconfluent, the culture medium was removed and the cells were treated with different doses (50, 10, 2, 0.4, 0.08, and 0.0016 ng/ml and untreated) of IFNG, infected with 1 M.O.I. of BoHV-4-A-LucDTK, and maintained in MEM with 2% FBS for 2 h. The medium was then removed and replaced with fresh MEM containing 10% FBS. In vivo imaging was performed 48 h after the infection using an IVIS imaging system (Caliper Life Sciences). Photons emitted were quantified using Living Image software (Caliper Life Sciences).
After the in vivo analysis the cells were fixed with 13 PBS þ 10% of paraformaldehyde for 15 min at RT. After washing with tap water the cells were colored with crystal violet (2% crystal violet and 2% formaldehyde) for at least 5min at RT, and then the monolayers were washed again in tap water and completely dried.
Reverse Transcription PCR
RT-PCR for BoHV-4 IE2 was performed on total RNA isolated by Trizol (Invitrogen) from infected BESCs, treated with 50 ng/ml of IFNG or not treated; glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as normalizing control. Three micrograms of RNA was reverse transcribed using the Ready to Go, T-Primed First-Strand Kit (Amersham Biosciences) according to the manufacturer's instructions. PCR amplification was carried out in a final volume of 50 ll containing 10 mM Tris-hydrochloride pH 8.3, 0.2 mM deoxynucleotide triphosphate, 3 mM MgCl 2 , 50 mM KCl, 5% dimethyl sulfoxide, and 0.25 lM of each primer. The primers used for the amplification of IE2 and GAPDH are listed in Table 1 . One hundred nanograms of cDNA samples was amplified over 30 cycles, each cycle consisting of denaturation at 948C for 1 min, primer annealing at 558C for 1 min, and chain elongation with 1 U of Taq DNA polymerase (Fermentas) at 728C for 30 sec. The so-generated 386 and 103 bp (IE2 and GAPDH) amplicons were then checked in 1% agarose gel and visualized after ethidium bromide staining in 13 Tris-acetate-EDTA buffer (40 mM Tris-acetate, 1 mM EDTA).
RT-PCRs for bovine IFNG, IFNGR1, and IFNGR2 were performed from total RNA isolated by Trizol (Invitrogen) from primary BESCs; 3 lg RNA was reverse transcribed as described above. The PCR amplification was carried out using GAPDH as in internal control and with the same reaction conditions used to amplify BoHV-4 IE2. The primers used for the amplification of IFNG, IFNGR1, and IFNGR2 are listed in Table 1 ; the 518-, 300-, and 227-bp amplicons were then checked in agarose gel.
RT-PCRs for bovine indoleamine 2,3-dioxygenase 1 (IDO1) and inducible nitric oxide synthase (iNoS) [31] were performed from total RNA isolated by Trizol (Invitrogen) from primary BESCs treated with different concentrations of IFNG or not treated, from BESCs' self-producing IFNG (BESCs/IFNG), and compared to mock-transfected or transduced BESCs (BESCs/Mock). Three micrograms of RNA was reverse transcribed as described above; the PCR conditions used were denaturation at 948C for 1 min, primer annealing at 568C for 1 min, and chain elongation with 1 U of Taq DNA polymerase (Fermentas) at 728C for 40 sec, for 30 cycles. GAPDH was used as internal control and the amplicons of 139, 372, and 103 bp, respectively, for IDO, iNOS and GAPDH, were checked in 2% agarose gel.
RT-PCRs for bovine IDO1 ORF were performed from total RNA isolated by Trizol (Invitrogen) from primary BESCs treated with IFNG, and 3 lg RNA was reverse transcribed as described above. The PCR conditions used were denaturation at 948C for 1 min, primer annealing at 568C for 1 min, and chain elongation with 1 U of Pfu DNA polymerase (Fermentas) at 728C for 90 sec, for 35 cycles. The primers used were NheI-bIDO1ORF sense and HindIIIbIDO1 ORF antisense (see Table 1 ). GAPDH was used as internal control; the amplicons of 1244 and 103 bp, respectively, for IDO1 ORF and GAPDH were checked in 2% agarose gel and the specificity of the PCR product was determined by sequencing.
Genomic DNA from primary BESCs and MDBK was also used to successfully amplify IDO promoter (;1.6 kb), using the primer bIDOprom sense and antisense (see Table 1 ). Genomic DNA was extracted with classical procedure: cells were lysed overnight in proteinase K buffer containing 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 0.5% SDS, and 100 lg/ml proteinase Kat 378C. Nucleic acids were extracted by treatment with phenol-chloroform and precipitated with ethanol. One microgram of DNA samples was amplified over 35 cycles, each cycle consisting of denaturation at 948C for 1 min, primer annealing at 558C for 1 min, and chain elongation with 1 U of Pfu DNA polymerase (Fermentas) at 728C for 2 min. The specificity of the PCR product was determined by sequencing.
Complementary DNA was also obtained from peripheral blood mononuclear cells stimulated with LPS; IFNG amplification was carried over for 35 cycles, with an initial denaturation step of 5 min at 948C, then 1 min of denaturation at 948C; 1 min of primer annealing at 558C and 1 min of primer extension at 728C were performed. Using the primer pair bIFNG sense and antisense (see Table 1 ) an amplicon of 518 bp was obtained, and was checked by sequencing.
Quantitative Real-Time PCR
Total RNA was extracted from BoHV-4-EGFPDTK-infected BESCs, treated with 50 ng/ml of IFNG or not treated, and reverse transcribed as described above. IE2 gene expression was measured by real-time PCR using the StepOne Real-Time PCR System (Applied Biosystem) and Maxima SYBR Green qPCR Master Mix (ROX Solution provided; Fermentas) starting with 50 ng of reverse-transcribed total RNA. GAPDH expression was used as an internal control using the primers listed in Table 1 (GAPDH sense and antisense). IE2 primers were chosen on the basis of IE2 exon 1 and exon II sequences matching (Table 1 ; IE2 sense and IE2 antisense). PCR parameters were the following: an initial denaturation at 958C for 5 min, followed by 40 cycles of 958C for 1 min, 558C for 30 sec, and 728C for 30 sec, with a final extension at 728C for 5 min.
Total RNA was also extracted from BESCs treated with different concentration of IFNG or BESCs/IFNG and compared to BESCs/Mock, and reverse transcribed as described above. IDO gene expression was measured by real-time PCR using the StepOne Real-Time PCR System (Applied Biosystem) and Maxima SYBR Green qPCR Master Mix (ROX Solution provided; Fermentas) starting with 50 ng of reverse-transcribed total RNA. GAPDH expression was used as an internal control using the primers listed in Table 1 (GAPDH sense and antisense). The primer pair used to amplify IDO was bIDO sense and antisense (see Table 1 ). PCR parameters were the following: an initial denaturation at 958C for 10 min, followed by 40 cycles of 948C for 20 sec, 568C for 30 sec, and 728C for 30 sec, with a final extension at 728C for 5 min.
Construct Generation
The pbIFNG was generated by subcloning the 518-bp amplicon, cut with NheI and XhoI, in the Multy Cloning Site (MCS) of pEGFP-C1 (Clontech), cut with the same enzymes. Construct functionality of pbIFNG was tested by Duo Set ELISA for bovine IFNG detection (R&D Systems), in cell supernatant of pbIFNG transiently transfected HEK 293T cells. The 1.6-kb IDO promoter was amplified by PCR from bovine genomic DNA and was cut with MluI and XhoI and inserted in pGL3basic (Promega), opened with the same restriction enzymes, to generate pbIDO1P-Luc.
The pbIDO1 was obtained after the PCR amplification of IDO cDNA (1244 bp) and the amplicon was cut with NheI/HindIII and inserted in pEGFP-C1 cut with NheI/HindIII.
The full promoter of BoHV-4 IE2 gene was subcloned in front of the reporter gene luciferase to generate pIE2prom-Luc [7] . Subsequently, pIE2promD225, pIE2promD450, pIE2promD675, and pIE2promD900 deleted constructs were obtained from pIE2prom-Luc.
The pIE2promD225 construct was obtained by subcloning a 905-KpnI/NheI amplicon, amplified by PCR from pIE2prom-Luc DNA with the primer pair
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KpnI-IE2D225 sense and NheI-IE2P antisense (listed in Table 1 ), in KpnI/NheIcut pGL3basic vector (Promega); pIE2promD450 construct was obtained by subcloning a 680-KpnI/NheI amplicon, amplified by PCR from pIE2prom-Luc DNA with the primers KpnI-IE2D450 sense and NheI-IE2P antisense (see Table 1 ), in KpnI/NheI-cut pGL3basic vector (Promega).
The pIE2promD675 construct was obtained by subcloning a 455-KpnI/NheI amplicon, amplified by PCR from pIE2prom-Luc DNA with the primer pair KpnI-IE2D675 sense and NheI-IE2P antisense (Table 1) , in KpnI/NheI-cut pGL3basic vector; similarly, pIE2promD900 was obtained by subcloning a 230-KpnI/NheI amplicon, amplified by PCR from pIE2prom-Luc DNA with KpnI-IE2D900 sense and NheI-IE2P antisense primers (Table 1) , in KpnI/NheIcut pGL3basic vector l.
Statistical Methods
For luciferase assay in Figure 1C , signal intensity was expressed as folds of induction for each treatment over the luciferase construct transfected and vehicle treated (untreated control ¼ 1). For luciferase assay in Figure 6 , C and D, signal intensity was expressed as percentage of luciferase activity for each treatment over that of the untreated control or that of cells transfected only with pIE2P-Luc (¼100%). For luciferase assay in Figure 7 , data are reported as percentage of luciferase activity by normalizing the signal for each deleted construct to that obtained with transfected but IFNG-untreated BESCs (¼100%). All luciferase assay experiments were repeated three times, with four replicates at each time point, and identical results were obtained. Results are reported as mean 6 SD and were considered significant when P 0.05. For all viral titers, the data are the means 6 SD of triplicate measurements and each infection was repeated eight times (P . 0.05 for all time points as measured by Student t-test or ANOVA). The quantitative real-time PCR data presented are the means 6 SEM of triplicate measurements (P 0.05) for all points as measured by Student t-test.
RESULTS
BESCs Express Functional IFNGR 1 and 2
A pure population of BESCs was prepared from healthy animals. The absence of immune cells in the BESC cultures was verified by RT-PCR for the CD45 pan-leukocyte marker (data not shown), and their stromal nature was assessed by immunostaining for vimentin (stromal marker) (Fig. 1A) . BoHV-4 has been shown to have a remarkable tropism towards BESCs that can be modulated by the innate immunity through several cytokines [10, 11, 22, 32, 33] ; in addition, these same substances can also tune the gene expression cascade of intracellular BoHV-4. Being that IFNG is an important bridge molecule between innate and adaptive immunity [34] , it was of interest to know if BESCs expressed and/or responded to this chemokine. As shown in Figure 1B , IFNGR1 and IFNGR2 transcripts were well expressed, whereas the IFNG ligand could not be detected (data not shown). To test BESC IFNGR functionality, a bovine IFNG-responsive gene promoter, IDO1, was first cloned from bovine genomic DNA. To this aim, starting from IDO1 locus, which is mapped on the Bos taurus chromosome 27 [35] , two primers spanning a 1.6-kb DNA sequence, containing the putative IDO1 gene promoter upstream of the IDO1 translational start codon (NM_001101866.2) and the full 5 0 untranslated region were first generated (Table 1 and Supplemental Fig. S1 ; Supplemental Data are available online at www.biolreprod.org). Then, using bovine genomic DNA from different sources as a template, the predicted 1.6-kb amplicon was generated by PCR, and verified first by restriction enzyme analysis and then by sequencing. Amplicon sequences from templates of different origins were all identical to that present in the data bank (data not shown). In order to quantify IDO1 promoter activation at the transcriptional level, a luciferase reporter construct (pbIDO1P-luc) was generated by subcloning the 1.6-kb IDO1 promoter in front of a luciferase reporter gene. When BESCs were transiently transfected with the pbIDO1P-luc reporter construct, and 24 h posttransfection were treated with different doses (0.005, 0.05, 0.5, 5, and 50 ng/ml) of IFNG, BESCs were well responsive to exogenous IFNG (Fig. 1C) .
IFNG Strongly Restricts BoHV-4 Replication in BESCs
Taking into account that BESCs are highly susceptible toward BoHV-4 infection [10, 11, 22, 32, 33] were used as a control and the outcome of the viral infection was monitored through time by fluorescence microscopy. BoHV-4 replication in IFNG-treated BESCs was strongly impaired respect to IFNG-untreated BESCs; EGFP expression, as well as the CPE induced by the virus replication, appeared only in IFNG-untreated BESCs, at 72 h P.I. (Fig. 2A) , and this was consistent with the increase of the viral titer when measured at 48 and 72 h P.I. (Fig. 2B) . A similar experiment was repeated without pretreating the cells with IFNG but simultaneously infecting and treating the culture. Nevertheless, although the IFNG effect was less intense as observable by an increase of EGFP expression at the first stage of infection, the result was similar to that obtained with the pretreatment (Supplemental Fig. S2 ). To quantitatively correlate the IFNG properties to restrict BoHV-4 replication, BESCs were treated with different doses (50, 10, 2, 0.4, 0.08, and 0.0016 ng/ml and untreated) of IFNG and infected, at the same time, with 1 M.O.I. of BoHV-4-LucDTK, a recombinant BoHV-4 expressing luciferase that allows monitoring of the progress of BoHV-4 infection with time by in vivo bioluminescence imaging (BLI) analysis. The experimental results showed that both the bioluminescence signal (Fig. 2C ) and the CPE (Fig. 2D) increased concomitantly with the decrease of IFNG concentration. All the experiments were repeated three times, and similar patterns of results were obtained.
Stably Transfected BESCs Expressing IFNG Are Resistant to BoHV-4 Replication
Aiming to support the data obtained on the capacity of IFNG to restrict BoHV-4 replication in BESCs, we prepared a line of this cell's self-producing IFNG. This allowed us to unquestionably demonstrate that IFNG produced by BESCs could induce an anti-BoHV-4 state in themselves (autocrine) or the nearby cells (paracrine) (Fig. 3A) . Thus, BESCs were stably transfected with a plasmid vector expressing IFNG (pbIFNG) to generate BESCs/IFNG, whereas as a negative control the same cells were transfected with the empty vector to generate BESCs/Mock. As expected, when BESCs/IFNG and BESCs/Mock were infected with a BoHV-4-EGFPDTK, the full BoHV-4 permissivity was observed only in control BESCs/Mock and not in BESCs/IFNG (Fig. 3B) . In fact, the viral titer measured at 48 and 72 h post-BoHV-4-EGFPDTK infection was much higher in BESCs/Mock than in BESCs/ IFNG (Fig. 3C) . Because BESCs are a primary culture, the drug selection to generate the stable transfected BESCs could be potentially detrimental to the physiology of the cells. Therefore, a similar experiment was done by transiently transfecting BESCs by electroporation with pbIFNG; alternatively, the cells were transduced with the lentiviral vector expressing IFNG; in both cases identical results were obtained (data not shown).
IFNG Treatment Tightly Induces IDO Expression in BESCs
Relying on previous data regarding the IDO1 gene promoter response to IFNG in BESCs revealed by a luciferase reporter assay, such transcriptional response was further investigated on the endogenous gene. BESCs were treated with different concentrations of IFNG (0.5, 5, and 50 ng/ml) for 12 h, and IDO1 mRNA was semiquantified by classical RT-PCR (Fig.  4A) , quantitative real-time PCR (Fig. 4B) , and Western immunoblotting IDO1 protein product (Fig. 4C) . In all cases, IDO1 transcription and translation increased with IFNG concentration. Moreover, when BESCs self-producing IFNG were compared to mock-transfected or transduced BESCs, similar results to those obtained treating BESCs with IFNG were obtained. IDO1 mRNA (Fig. 4, D and E) and IDO1 protein (Fig. 4F) were found to be up-regulated in BESCs selfproducing IFNG with respect to those mock transfected or
FIG. 1. IFNGR1 and IFNGR2 expression in BESCs.
A) Phase-contrast and fluorescent images (magnification 320) of BESCs expressing the stromal marker, vimentin (red rhodamine staining). Counterstained nuclei with DAPI were merged with red fluorescent image (merge). B) Qualitative IFNGR1 and IFNGR2 gene expression in BESCs. RNA was isolated as described, and the resulting cDNA was analyzed by PCR for the presence of IFNGR1 and IFNGR2 gene transcripts using the primer pairs described in Table 1 . No reverse-transcribed RNA was used as a negative control (data not shown). GAPDH expression was used as an internal control and amplified with primer pairs described in Table 1 . Amplicon molecular size is present beside each amplicon band. C) Dose-dependent IDO1 response of IFNG-treated BESCs with respect to the untreated control (unt.). Results are reported as mean 6 SD and are considered significant when P 0.05 (*). 
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transduced, whereas inducible nitric oxide synthase (iNOS) gene transcript, another IFNG-nducible gene product with bacteriostatic and virostatic properties [36] , could not be detected (data not shown).
IFNG-Mediated BoHV-4 Replication Restriction in BESCs Is IDO1 Independent
IDO1 is a rate-limiting enzyme in the breakdown of the essential amino acid tryptophan within a highly conserved metabolic pathway. It was originally described for its antimicrobial role, depleting the tryptophan essential for the replication of some microbial pathogens [37] . Therefore, a possible relationship between IFNG-mediated BoHV-4 replication restriction and IDO1 expression was hypothesized. To test this hypothesis, BESCs were treated with IFNG in the presence or absence of 1-MT (IDO1-specific inhibitor), as well as in the presence or absence of an excess of tryptophan to counteract its depletion, and then infected with 0.1 M.O.I. of BoHV-4EGFPDTK. Seventy-two hours post-treatment/infection, BESCs were microscopically monitored for the appearance of the CPE, and supernatant viral titer was measured. Surprisingly, both 1-MT and extra tryptophan supplementation could not relieve IFNG-mediated BoHV-4 replication restriction in BESCs, either in terms of viral titer or CPE (Fig. 5A) . Similarly, no differences in terms of viral titer or CPE were observed between BoHV-4-infected BESCs constitutively expressing IDO1 (BESCs/IDO1) and the control unexpressing IDO1 (BESCs/Mock) (Fig. 5B) .
IFNG-Mediated BoHV-4 Replication Restriction in BESCs Is
IE2 Dependent
The BoHV-4 gene expression program is controlled by the essential immediate-early lytic switch gene 50, which is the only gene needed to initiate BoHV-4 lytic replication during de novo infection [38] . Gene 50 encodes the Rta protein, which transactivates a number of viral and cellular genes by directly binding to Rta-responsive elements in target promoters, or via indirect measures involving interactions with unknown cellular transcription factors. The regulation of the gene 50 promoter itself is poorly characterized. Therefore, the potential correlation between IFNG axis activation, BoHV-4 gene 50 expression, and BoHV-4 lytic replication was investigated. (Fig. 6A) and quantitative real-time PCR (Fig. 6B) . IE2 expression was strongly reduced in IFNG-treated cells with respect to the untreated control (Fig. 6, A and B) . To understand if the IE2 promoter was directly involved in this effect, BESCs were transfected with a reporter construct expressing luciferase under the control of the IE2 promoter (pIE2P-Luc), and then treated with different concentrations of IFNG (50, 5, and 0.5 ng/ml and untreated). Luciferase activity was strongly reduced in treated BESCs with respect to untreated (Fig. 6C) . These data were confirmed when BESCs were cotransfected with pIE2P-Luc and with the effector construct expressing IFNG, pbIFNG. Luciferase activity was strongly reduced in cotransfected cells with respect to the control cells transfected with pIE2P-Luc and pEGFP-C1 (Fig. 6D) .
IFNG-Mediated BoHV-4 IE2 Transcription DownRegulation Resides Within IE2 Promoter Gene
To identify the IE2 promoter region responsive to a potential transcriptional inhibitor induced in IFNG-treated BESCs, a series of four deleted (D225, D451, D675, and D900) fragments of the BoHV-4 IE2 gene 1146-bp promoter (À1130 to þ16 bp) was amplified by PCR and cloned into the pGL3-Basic vector reporter plasmid. The promoter fragments in the resulting reporter plasmids shared the same 3 0 end, with the 5 0 beginning at bases À905 (D225), À680 (D450), À455 (D675), and À230 (D900) respectively. These plasmids were transfected into BESCs and transfected BESCs were either treated or not treated with 50 ng/ml of IFNG for 12 h. Loss of IFNG response in IE2 promoter, as indicated by the luciferase activity reduction following IFNG treatment, was observed for deletions between À680 and À455 (Fig. 7) . It is noteworthy that the D900 promoter maintained the level of luciferase expression similar to the unstimulated full promoter. Thus, a response element as a target site for unknown transcriptional inhibitors appeared to be contained between the IE2 gene promoter positions À680 and À455.
DISCUSSION
The initial defense of the mammalian endometrium against microbes is dependent on the innate immune system, including toll-like receptors (TLRs), antimicrobial peptides, and complement system and acute-phase proteins. Microorganisms are detected by pattern recognition receptors on mammalian cells binding molecules specific to microbial organisms, often called pathogen-associated molecular patterns [39] . Activation of TLRs initiates signaling cascades, resulting in the synthesis and production of proinflammatory cytokines and chemokines that mobilize and activate immune cells, which in the case of bovine uterine diseases is particularly associated with the influx of polymorphonuclear cells from the blood into the uterus [1] . The endometrium from normal, nonpregnant cattle expresses TLR1 through TLR10. Before and after parturition, TLR2, TLR3, TLR4, TLR6, and TLR9 are expressed in the caruncular and intercaruncular endometrium, and TLR expression is higher in the caruncular endometrium than in the intercaruncular 4-6 h postpartum endometrium. Purified populations of epithelial cells express TLR1 through TLR7 and TLR9, and stromal cells express TLR1 through TLR4, TLR6, TLR7, 
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TLR9, and TLR10 and these TLRs appear to be functional [40] . The innate immune response gives a crucial contribution to the activation of adaptive immunity, which is essential for the clearance of the pathogen. The inflammatory response increases the flow of both specialized immune cells and antigen-bearing cells from the site of primary infection to lymphoid tissue and vice versa. Macrophages that have phagocytosed bacteria or viruses and become activated can also activate T lymphocytes and initiate an adaptive immunity. Limited information is available about the interface between innate and acquired immunity in case of uterine infection, especially if it has been induced by viral infection, as is the case for BoHV-4. Like other herpesviruses, BoHV-4 establishes persistent infections both in its natural host and in the rabbit experimental host [41] [42] [43] . Latent infections can be reactivated in vivo by dexamethasone treatment [41] [42] [43] . The presence of BoHV-4 has been demonstrated in many tissues during persistent/latent infection by both PCR [44, 45] and in situ hybridization [46] , or by the recovery of the virus after the explant culture [4, [41] [42] [43] 47] . Peripheral blood leukocytes and lymphoid organs are the sites of persistent/latent BoHV-4 infection most consistently detected [4, [41] [42] [43] [44] [45] [46] [47] . Identification of BoHV-4 in non-T, non-B cells located in the marginal zone of the spleen of persistently/latently infected cattle and rabbits has implied that cells of the monocyte/macrophage lineage are a site of persistent/latent BoHV-4 infection [46, 47] , which is a finding that was corroborated by an in vitro model [5] .
BoHV-4 persistently infected macrophage mobilization from the peripheral lymphatic sites to the inflamed uterus represents the most probable pathway that allows BoHV-4 to reach the uterus stromal layer, a fertile cellular substrate where the virus can actively replicate. However, in some cases, as for persistently infected healthy animals, because of the establishment of a local antiviral state through a potential unknown factor interfering with stromal cells, BoHV-4 replication and uterus inflammation are limited or absent. In the search for a BoHV-4 replication limiting factor, IFNG was the best candidate for several reasons: first of all, IFNG is traditionally recognized to be an antiviral molecule [48] , although it was never tested for BoHV-4 before this work; second, an increase of IFNG level could be detected in BoHV-4-infected animals [20] ; and third, IFNG has been shown to be protective against many intracellular pathogens, such as Chlamydia [49] , Mycobacteria [50] and N. caninum [21, 51] . In fact, when pure-population second-passaged BESCs were tested for the presence of IFNGR transcripts, both receptor transcripts were found to be well expressed, whereas the IFNG ligand transcript or protein could not be detected. Thus, other cells lying into the endometrial stromal layer must be the source of IFNG ligand for the receptor expressed on the BESC surface. IFNG is the only type II IFN family member, and the primary sources of IFNG are CD8, CD4 Th1 effector T cells, B cells, professional antigen-presenting cells (APCs) of the adaptive immune system, NK cells, and NK T (NKT) cells, which are effectors of the innate immune response [52] . NK and NKT cells constitutively express IFNG mRNA, which allow for the rapid induction and secretion of IFNG on infection. In contrast to NK and NKT, naive CD4 and CD8 T cells produce little amounts of IFNG immediately following their initial activation. However, naive CD4 and CD8 T cells can gain the ability to efficiently transcribe the gene encoding IFNG over several days, in a process that is dependent on their proliferation, differentiation, up-regulation of IFNG-promoting transcription factors, and remodeling of chromatin within the IFNG gene locus. Naive CD8 T cells are programmed to differentiate into IFNG-producing cytotoxic effector lineages, of which only Th1 CD4 effector T cells produce substantial amounts of IFNG. The process of effector differentiation in CD4 T cells, and to a lesser extent in CD8 T cells, is influenced by the nature of the infecting pathogen and of the cytokine milieu emanating from the innate immunity system in response to the pathogen. These differences in priming conditions, in turn, can result in stable changes to the chromatin structure of the gene encoding IFNG, either facilitating high-level expression in Th1 CD4 and CD8 effector T cells or silencing expression in other effector lineages. Because these cellular types have been found to be primarily located in the stromal layer of the bovine endometrium [23, 53] , it can be hypothesized that IFNG ligand locally BESCs were cotransfected with the target plasmid (pIE2P-Luc) and the effector plasmid (pbIFNG), whereas the control was established by cotransfecting pIE2P-Luc with pEGFP-C1, so that the total amount of DNA cotransfected remained the same. Results are reported as mean 6 SD and were considered significant when P 0.05 (*).
produced from these cells can paracrinally interact with IFNGRs displayed on the surface of BESCs. Because IFNG is recognized as a strong gene transcription inducer [54] , and IDO1 gene transcription is strongly induced by IFNG [55] , to test the response and functionality of IFNGRs displayed on the surface of BESCs, a luciferase reporter construct based on bovine IDO1 gene promoter was generated by cloning, for the first time, the bovine IDO1 gene promoter from bovine genomic DNA. As a matter of fact, when bovine IDO1 gene promoter reporter construct was transfected in BESCs, it properly responded to IFNG treatment. BESCs exert fundamental functions sensing microorganisms, such as bacteria and viruses, implicated in uterine diseases [1] ; therefore, the presence of functional IFNGRs on their surface, unveiled here for the first time, adds new insights to the function of this uterine stromal sensing device.
Gamma interferon is an important negative regulator of chronic murine c-herpesvirus 68 (MHV68) infection. MHV68-persistently infected cells explanted from IFNGR-deficient mice exhibit increased reactivation and high levels of replication compated with those found in control mice [56, 57] . Although it is clear that IFNG signaling is crucial for the control of chronic gammaherpesvirus in mice, as a tractable small-animal pathogenesis and immunologic model for understanding the dynamics and genetics of gammaherpesvirus infection in vivo, the same cannot be stated for BoHV-4 in bovine. The use of ruminants as animal model is very expensive and demanding in terms of maintenance, and the availability of advanced genetic or immunologic resources is significantly limited when compared with those available for rodent studies. Thus, the impact of IFNG on BoHV-4 lytic replication in BESCs was tested ex vivo using a pure population of BESC primary cultures. IFNG treatment of BESCs strongly impaired BoHV-4 replication with respect to the untreated control; this was quantitatively shown by different methods, either pretreating or posttreating BESCs with IFNG, and it was confirmed by establishing BESCs selfexpressing IFNG. Although these data revealed the crucial role of IFNG signaling during BoHV-4 infection in BESCs, the anti-BoHV-4 molecular mechanism involved at the cellular level was completely unknown. Thus, the potential involvement of IDO1 was investigated. IDO1 is the gene most activated by IFNG, and the IDO1 promoter has sequence elements that confer responsiveness to this cytokine [58] . This transcriptional response was shown for the first time in the present work for BESCs treated or constitutively expressing IFNG.
IDO1 enzyme is a single-chain oxidoreductase catalyzing the first, rate-limiting step of tryptophan degradation in the biosynthesis of the central metabolic regulator NAD along the kynurenine pathway. In mammals, IDO1 does not catabolize excess dietary tryptophan, which is carried out by liver enzyme tryptophan 2,3-dioxygenase (TDO2), and NAD levels are not maintained by synthesis, but rather by recovery from diet. Thus, the role of IDO1 in mammalian was obscure until it was discovered to be strongly induced by IFNG and linked to its antimicrobial role, depleting tryptophan essential for the replication of some microbial pathogens [37, 59] such as bacteria and viruses [60, 61] , but it has also been found to be a potent immunoregulatory molecule in pregnancy and long-term immune responses, including chronic infections and tumors [37, 59] . For these reasons, IDO1 expression was hypothesized to be potentially responsible for the BoHV-4 replication restriction in IFNG-treated BESCs. However, IDO1 inhibitors FIG. 7. IE2 promoter gene analysis. Deletion constructs were designed with numbering relative to transcriptional start site (þ1) and the resulting deletion at their 3 0 end. They correspond to pIE2P-luc (À1130, undeleted full promoter), pIE2PD225-luc (À905), pIE2PD450-luc (À680), pIE2PD675-luc (À455), and pIE2PD900-luc (À230). 225 bp indicates the region between À680 and À455. Results are reported as mean 6 SD and were considered significant when P 0.05 (*).
could not abrogate BoHV-4 replication restriction in IFNGtreated BESCs, and IDO1 constitutively expressed in BESCs could not recapitulate IFNG's effect on BoHV-4-infected BESCs. From these data it could be stated that IFNG-mediated BoHV-4 replication restriction in BESCs is IDO1 independent, at least in our experimental setting, and in contrast with what has been found for other viruses, bacteria and parasites [37] . Hence, a molecular mechanism different from the IDO1-related mechanism had to be associated with IFNG BoHV-4-static activity in BESCs. Herpesvirus immediate early (IE) genes do not require prior viral protein synthesis for their expression because their expression is activated by host cell transcription factors that already present at the moment of infection and are thus expressed ''immediately'' during cell infection [62] . BoHV-4 IE2 protein (homologous to Epstein-Barr virus replication and transcription activator, Rta, and thus designated BoHV-4 Rta) encoded by open reading frame 50 (ORF 50) is well conserved among gammaherpesviruses [63] . BoHV-4 IE2 RNA is a spliced, 1.8 kb RNA, which is transcribed from left to right on the restriction map of the BoHV-4 genome from DNA contained in the 8.3-kb HindIII fragment F, and is the less abundant of two IE RNAs encoded by BoHV-4 [9, 64] . Recombinant ORF50-deleted BoHV-4 was efficiently rescued, with respect to production of infectious virus and DNA replication, upon the expression of ORF50/Rta in trans [38] . BoHV-4 Rta expression plays a primary role in initiating viral lytic replication, not only during reactivation of latently infected nonpermissive cells, but also during de novo infection of permissive cells [9, 65, 66] . On the basis of these findings, the hypothesis that IFNG inhibits lytic replication via ORF50/ Rta expression in BoHV-4-infected BESCs was tested. Indeed, IFNG treatment strongly decreased ORF50 transcript to an undetectable level in BoHV-4-infected BESCs, and the regulation of the BoHV-4 IE2 gene promoter itself was directly involved, as shown by IE2 gene promoter-driven luciferase transfected in IFNG-treated BESCs. IFNG suppressed BoHV-4 IE2 gene promoter in a dose-dependent manner, and this repression very likely contributes to the decrease in ORF50 transcript level for virally infected and IFNG-treated BESCs. The presence of potential BoHV-4 IE2 gene promoter inhibitory transcription factors induced by IFNG and the binding of still-unknown responsive elements within BoHV-4 IE2 gene promoter were shown by BoHV-4 IE2 gene promoter mutant deletions; therefore, these data further corroborate the hypothesis that indicates the dependency between IFNG-mediated BoHV-4 replication restriction in BESCs and BoHV-4 IE2 gene expression.
IFNG signaling regulates positively hundreds of cellular genes, whereas it regulates negatively a small number of genes [67] . IFNG-mediated gene expression is very complex and, to date, not completely understood. IFNG exerts its effects by interacting with a specific receptor composed of two subunits, IFNGR1 and IFNGR2. Binding of IFNG to its receptor induces oligomerization of the receptor, which activates by transphosphorylation the receptor-associated Janus kinases Jak1 and Jak2. The activated Jaks then phosphorylate the intracellular domain of the receptor, which behaves as a docking site for Stat1 that, after phosphorylation, undergoes dimerization. Finally, the active form of Stat1, translocates to the nucleus, where it regulates gene expression through binding to cactivated sequence elements in the promoters of IFNGregulated genes. The physiological relevance of IFN-dependent signaling through the Jak-Stat pathway has been established by generating and characterizing mice with a targeted disruption of the Stat1 encoding gene [68] . Although significant progress has been made on the identification of signaling molecules that respond to IFNG, many questions remain to be answered about the signal-transduction pathways involved and their roles in the regulation of gene expression. In seminal works [69, 70] performed by microarray analyses on wild-type and Stat1-null bone-marrow-derived macrophages (BMMs), untreated or treated with IFNG, it has been demonstrated that IFNG predominantly regulates the induction of gene expression in wild-type BMMs when compared with the suppression observed in Stat1-null BMMs; therefore, virtually, IFNGmediated BoHV-4 IE2 gene expression reduction could be assigned to a Stat1-independent pathway in IFNG-dependent signaling.
Although in the present work the IFNG-dependent signaling inhibitory transcription factors involved on the BoHV-4 IE2 gene promoter suppression have not been identified, without any doubt a new piece to the puzzling role of BoHV-4 as a cofactor for bovine postpartum metritis outcome has been added, as can be summarized in the following model. During parturition, infection of the uterus can take place from environmental bacteria. If this happens in BoHV-4-persistently infected animals, the inflamed uterus attracts BoHV-4-persistently infected macrophages from the periphery to the site of inflammation. BoHV-4 replication in normoergic animals is maintained under control by IFNG secreted by uterine resident T lymphocytes, NK cells, B cells, and professional APCs, through BoHV-4 IE2 gene down-regulation. In these IFNG-responsive animals the uterine acute infection (metritis) can be generally cleared within 3 wk [1, 6] , whereas in animals with an impaired IFNG axis response, where BoHV-4 replication is no longer under control, it is actually enhanced by inflammatory molecules, such as LPS, PGE2 and TNFA, produced by the inflamed endometrium and proliferating bacteria. These inflammatory molecules, in contrast to IFNG, up-regulate the BoHV-4 IE2 gene [9, 66] whose protein products ORF50/Rta, inducing not only BoHV-4 replication but also IL-8 production [10] , thus shifting the inflammation from a transitory and acute status (metritis) toward a chronic status (endometritis) (summarized model in Fig. 8) .
In humans, disorders of IFNG production, caused by IL12B, IL12RB1, and specific NEMO mutations, or of IFNG responses, caused by IFNGR1, IFNGR2, and dominant STAT1 mutations, can drive different types of diseases. In bovine, disorders of IFNG production or response have not been associated to a specific disease so far. With regard to this, the present investigation, although it has been performed as an ex vivo study, clearly shows that a bovine reproductive disease involving the recrudescence of a latent viral infection can be completely, or at least in part, determined by an impaired IFNG production or response.
